Woods C J, Ellis-Pegler R B
Drugs. 1981;22 Suppl 1:96-9. doi: 10.2165/00003495-198100221-00020.
17 hospitalised patients with a wide variety of common lower respiratory tract infections received at least 6 days of intravenous bolus cefoperazone 1.0g 12-hourly. Disease was caused by Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus aureus, and mixed anaerobes in 1 patient. All isolates were sensitive to cefoperazone. 11 patients were cured, 4 improved, and 2 failed (1 of whom had an anaerobic empyema). Toxicity and side effects were infrequent. In general cefoperazone was effective therapy for these infections.
17名患有各种常见下呼吸道感染的住院患者接受了至少6天的静脉推注头孢哌酮治疗，剂量为1.0g，每12小时一次。疾病由流感嗜血杆菌、肺炎链球菌、金黄色葡萄球菌引起，1名患者为混合厌氧菌感染。所有分离株对头孢哌酮敏感。11名患者治愈，4名患者病情改善，2名患者治疗失败（其中1名患有厌氧性脓胸）。毒性和副作用不常见。总体而言，头孢哌酮对这些感染是有效的治疗方法。
